Healthcare & PharmaceuticalsIndia's Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose

Reuters
1 minute read

Officials unload boxes containing vials of AstraZeneca's COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, outside a vaccination storage centre in Ahmedabad, India, January 12, 2021. REUTERS/Amit Dave

The Serum Institute of India said on Wednesday it would sell the AstraZeneca (AZN.L) vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95).

"Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems."

($1 = 75.4620 Indian rupees)

Our Standards: The Thomson Reuters Trust Principles.